Biomedical interventions to prevent HIV infection: evidence, challenges, and way forward NS Padian, A Buvé, J Balkus, D Serwadda, W Cates The Lancet 372 (9638), 585-599, 2008 | 364 | 2008 |
High global burden and costs of bacterial vaginosis: a systematic review and meta-analysis K Peebles, J Velloza, JE Balkus, RS McClelland, RV Barnabas Sexually transmitted diseases 46 (5), 304-311, 2019 | 352 | 2019 |
Weighing the gold in the gold standard: challenges in HIV prevention research NS Padian, SI McCoy, JE Balkus, JN Wasserheit Aids 24 (5), 621-635, 2010 | 283 | 2010 |
An empiric HIV risk scoring tool to predict HIV-1 acquisition in African women JE Balkus, E Brown, T Palanee, G Nair, Z Gafoor, J Zhang, BA Richardson, ... JAIDS Journal of Acquired Immune Deficiency Syndromes 72 (3), 333-343, 2016 | 160 | 2016 |
Bacterial vaginosis and the risk of Trichomonas vaginalis acquisition among HIV-1–negative women JE Balkus, BA Richardson, LK Rabe, TE Taha, N Mgodi, MP Kasaro, ... Sexually transmitted diseases 41 (2), 123-128, 2014 | 114 | 2014 |
Antiretroviral-associated toxicity among HIV-1-seropositive pregnant women in Mozambique receiving nevirapine-based regimens L Jamisse, J Balkus, J Hitti, S Gloyd, R Manuel, N Osman, M Djedje, ... JAIDS Journal of Acquired Immune Deficiency Syndromes 44 (4), 371-376, 2007 | 90 | 2007 |
Interaction between lactobacilli, bacterial vaginosis-associated bacteria, and HIV Type 1 RNA and DNA Genital shedding in US and Kenyan women C Mitchell, JE Balkus, D Fredricks, C Liu, J McKernan-Mullin, LM Frenkel, ... AIDS research and human retroviruses 29 (1), 13-19, 2013 | 86 | 2013 |
Preclinical safety assessments of UC781 anti-human immunodeficiency virus topical microbicide formulations DL Patton, YTC Sweeney, JE Balkus, LC Rohan, BJ Moncla, MA Parniak, ... Antimicrobial agents and chemotherapy 51 (5), 1608-1615, 2007 | 76 | 2007 |
Association of Recent Bacterial Vaginosis With Acquisition of Mycoplasma genitalium EM Lokken, JE Balkus, J Kiarie, JP Hughes, W Jaoko, PA Totten, ... American journal of epidemiology 186 (2), 194-201, 2017 | 73 | 2017 |
Randomized trial of periodic presumptive treatment with high-dose intravaginal metronidazole and miconazole to prevent vaginal infections in HIV-negative women RS McClelland, JE Balkus, J Lee, O Anzala, J Kimani, J Schwebke, ... The Journal of infectious diseases 211 (12), 1875-1882, 2015 | 69 | 2015 |
Relationship of specific bacteria in the cervical and vaginal microbiotas with cervicitis LM Gorgos, LK Sycuro, S Srinivasan, TL Fiedler, MT Morgan, JE Balkus, ... Sexually transmitted diseases 42 (9), 475-481, 2015 | 66 | 2015 |
Risk of HIV-1 acquisition among women who use different types of injectable progestin contraception in South Africa: a prospective cohort study LM Noguchi, BA Richardson, JM Baeten, SL Hillier, JE Balkus, ... The lancet HIV 2 (7), e279-e287, 2015 | 60 | 2015 |
Efficacy of oral pre-exposure prophylaxis (PrEP) for HIV among women with abnormal vaginal microbiota: a post-hoc analysis of the randomised, placebo-controlled Partners PrEP Study R Heffron, RS McClelland, JE Balkus, C Celum, CR Cohen, N Mugo, ... The lancet HIV 4 (10), e449-e456, 2017 | 53 | 2017 |
Bacterial vaginosis, not HIV, is primarily responsible for increased vaginal concentrations of proinflammatory cytokines CM Mitchell, J Balkus, KJ Agnew, S Cohn, A Luque, R Lawler, ... AIDS research and human retroviruses 24 (5), 667-671, 2008 | 53 | 2008 |
Age-disparate partnerships and risk of HIV-1 acquisition among South African women participating in the VOICE trial JE Balkus, G Nair, ET Montgomery, A Mishra, T Palanee-Phillips, ... JAIDS Journal of Acquired Immune Deficiency Syndromes 70 (2), 212-217, 2015 | 51 | 2015 |
Periodic presumptive treatment for vaginal infections may reduce the incidence of sexually transmitted bacterial infections JE Balkus, LE Manhart, J Lee, O Anzala, J Kimani, J Schwebke, J Shafi, ... The Journal of infectious diseases 213 (12), 1932-1937, 2016 | 48 | 2016 |
Detection of hydrogen peroxide-producing Lactobacillus species in the vagina: a comparison of culture and quantitative PCR among HIV-1 seropositive women JE Balkus, C Mitchell, K Agnew, C Liu, T Fiedler, SE Cohn, A Luque, ... BMC infectious diseases 12, 1-5, 2012 | 43 | 2012 |
Assessing the effect of hormonal contraception on HIV acquisition in observational data: challenges and recommended analytic approaches CB Polis, D Westreich, JE Balkus, R Heffron Aids 27, S35-S43, 2013 | 42 | 2013 |
A prospective cohort study comparing the effect of single-dose 2 g metronidazole on Trichomonas vaginalis infection in HIV-seropositive versus HIV-seronegative women JE Balkus, BA Richardson, V Mochache, V Chohan, JD Chan, L Masese, ... Sexually transmitted diseases 40 (6), 499-505, 2013 | 42 | 2013 |
Effects of pregnancy and bacterial vaginosis on proinflammatory cytokine and secretory leukocyte protease inhibitor concentrations in vaginal secretions J Balkus, K Agnew, R Lawler, C Mitchell, J Hitti Journal of pregnancy 2010, 2010 | 42 | 2010 |